Member Info for PM2022

Worth pointing out that they have to sell a placing in the coming months if needed, unlikely it will just drop randomly. They need news and delivery to sell it or it will likely go down to the wire.

Investors want to see 401 or 201 both projected before year end, or maybe one of the two evaluations coming through would be good. Either way I would expect significant news flow first.

Projected to have cash until Feb 2025 but lab revenue can extend this or obviously 201.

EUDA valued at about $160 million. Therefore leaves a chance for the merger to complete as hard to see why they have such a high valuation, 401 to complete and also a significant update on CLX, Imperial.

If they can get this 4/5p then they could one away at a decent price. The good part of merger completes and 201 is signed this will likely gap up a decent amount.

It will likely go up 500% plus from this price if the deal is signed anyway given the milestones in the deal.

The only clue we have is the EUDA market cap, it is around 100 million and has really kept rising recently so I think news must be imminent. Also I would rather stick to official information than listen to anyone else but that is just me.

Out until late so no more responses.

Well the new board seems confident so don't ask me. Your trusted people on the board are confident so we should be if not what is the purpose of change. All contradictions.

Anyway we shall see. Have a good weekend I don't think people want to read my replies.

Nick you were telling us exactly the same on Telegram.

Market conditions have changed including delays to 201. Most AIM biotechs are undervalued at the moment but especially Val for various reasons.

That was before the upfront payments were announced, partner announcement and subsequent delays. It is highly unusual to get less than 10 million at least for a phase 2 drug but in fact it should be many multiples of that but I can understand the issues with 201 being a bit different but still it was far lower than anticipated given how much Valirx has spent on development of 201 plus positive findings against potential. I still hold the view we should be at a certain market cap so nothing has changed but other decisions are made and have been made that are not right in my view that also impact events and share price.

I think I have been transparent with my views but at the same time decisions have been made that have unexpected which has impacted momentum as well with the company being targeted by trolls along with market conditions.

Thanks Fred. Not worth the energy so enjoy your weekend and leave them to it.

Hypocrites when you say one word against them they create a big fuss but here they are making accusations and assumptions.

Funny it all comes from non investors or those with little holdings compared to the usual amounts they would hold.

I have no connection to Kevin. I don't even trade this stock so complete nonsense had I been trading I would also be deramping.

I believe in the strategy and the products but I do not agree with the recent decision making. It can never be good for a company with no CEO or Chairman and yes to some degree I believe th a good job building the business but could have made better decisions that would have had more of a positive impact oey didn the share price. I don't see how Kevin leaving when Suzy is also stepping down can be seen to be positive but pointless making these comments when I have no control or say over those decisions which I agree are wrong.

Keeping away from the board as it was and is full of people that are not invested so a waste of energy.

Post about the stock and stop provoking trouble because what I post don't fit your agenda. I remain hopeful purely because of the rise in the EUDA market cap but other than that the recent events have been disruptive and I am not the person behind those actions. I have also stated previously I was against widespread changes and stood my ground on that.

The issue with this company is that it is dictated by non investors or those that listen to them which is why I calmed down with the posting recently.

If you really thought that you would not be on the board trying to buy more at a cheaper price or holding any. A bit contradicting.

Are you a fan of anything else other than posting on a stock you have not invested in for the last 3 years? If you don't like sports perhaps try a dating website as women might give you the attention you deserve.

What matters is a collection of contracts so we got one and more will come this year. All this will increase cash reserves past early 2025 to maybe late 2025. Val 201 is still due to be completed this year so I would think that we are at the bottom now so we should rise significantly in the next 6 months.

The number of prospective clients in the sales pipeline for Inaphaea's services and products is continuing to grow, with 11 at an advanced stage of discussion. This includes both screening and licencing of patient derived cells ("PDC"). Interest has been expressed from a range of end users, including biotech companies, large pharma and large CROs. The latter sector is of particular importance as we believe their requirements are substantive and likely to lead to longer term product supply relationships. Although the needs of the individual clients are varied, their decision-making timelines have been impacted by a number of factors, both internal and external, and generally characterised by longer lead times. We maintain regular dialogue with all key clients and, subject to their indicated decision processes and timelines, anticipate that several of the pipeline opportunities could be executed in H2 2024.

First of many contracts. Collectively it will show Valirx is making decent revenue with low cash burn if capital is required next year so hopefully a gradual rise until then with bigger news to come.

It makes sense. More to do with a lack of understanding of what they are doing.

Preclinical testing costs millions. Offering such a service will bring in big revenues but at the same time you have access through collaborations and our own lab to improve efficiency of the compounds we have in the most time consuming manner to produce the best results possible therefore allowing for a more valuable deal far quicker than without all this. Other external work we take on also will benefit from what Valirx offers through the lab helping bring in more revenue.

Northern,

All you had was 201,301 and 401. Not easy to get a deal with those old compounds. If you had a better solution then post it but they have done a decent job to be fair. A few things could have been better such as taking Adam on before he joined APTA so not all perfect but the science part has been good along with the low risk strategy.

As I said before most of the building phase is now complete so we should start seeing decent news coming through. Lack of progress on 201 was unfortunate but nothing to say it will not come good. Judging by the EUDA market cap it looks like the merger will complete. Also new board members would have pulled it if no progress was made.

With only 130 million shares the situation is completely reversible but only before the next placing. They will know this and need to get out substantial news in the next 6 months. I am sure they will and we will be double figures by then.

Yes because otherwise we would have an echo chamber of non investors trashing the company and causing panic. If this board was like other AIM companies I would not feel the need to post but people hide away or let others like Porky dictate.

This board is for investors or serious people looking to invest. Spending 3 years posting day in day out posting nonsense and not investing is not being serious.

Whilst we are dictated by non investors the company will never move forwards. I believe this is a big reason why we are where we are. All perception which is driven by non investors so Investors need to stand up. The likes of Porky create doom and gloom but it is all agenda driven.

We let the opinion of these people dictate our thoughts. Other than 201, the set up of the lab, promising evaluation projects , CLX, finances are fairly good. Once one deal gets over the line then people will understand and as contracts arrive shortly again people will realise.

The current SP is not where we should be it presents an opportunity if one can think for themselves and DYOR imo. Progress is incremental even with 201 so hopefully we will cross the line soon.

You can try and deceive people all you want but history shows you got it wrong every time. All the fools that followed you on 4D and lost money, NYCT calls of £50 plus, He1, VAL-150p plus. Even the calls for a placing at 1p was a joke. DYOR rather than trying to give credibility to a complete fraudster like you.

Poor market conditions and unexpected delays on 201 is not justification for you being anyway near correct. I would not sell then encourage others to come here and attack the company and shareholders to buy in cheaper. Out of order and in your case Porky you have no reason to be here as you are not invested or have any intention to invest.

hardly ramping you doughnut when we are worth only 1/2 million minus cash. why the **** did you invest at such a higher price when the assets have clearly progressed and are worth more than they were yet you call it ramping at these prices with most assets valued at zero. another trash on the lse website posting junk with no common sense.

we all know what the intentions were and he admitted he sold some. i would think the part he maybe holding is the historical holding worth **** all.

this is not about listening to someone it is about research. only an idiot would sell when everyone knows we have so much news due and cash until early 2025 with a very decent chance for a strong rise if 201 completes or when several lab contracts come our way before the need for further cash. it just shows the complete lack of research. imo.

Porky

So If Baldy holds in such high regards then he would not be invested. If he was then he agrees we have upside from where we are. All agenda driven and finally he has exposed himself.

Nobody disputes a chance of a placing next year, all about the price when it happens. If we are much higher dilution will be far less.

Clearly the EUDA merger looks on and to be honest we will find out well before any call for further cash. Also BOD will likely get share options so for them to reach the target they will need outcomes in the next 6 months.

Just exposes the twat for what he is. He wants him to come back and attack holders then give him credibility to say he is right.

Always thought he was fake and sly but I would take note if I was Adam, Rightback and others. Had to mention placing and inviting him to attack us when it is clear Valirx has cash until 2025 so plenty of opportunities for the SP to rise.